Major new appetite regulator successfully manipulated in mice

June 13, 2017
Credit: Martha Sexton/public domain

Researchers from Imperial College London and colleagues have found a potential way to target the receptors that specifically control appetite in mouse brains, potentially without causing other side effects.

Thyroid receptors (TRs) are spread widely throughout the body and interact with circulating hormones to regulate functions such as appetite, the nervous system, body temperature, and cholesterol levels. Thus, any targeting thyroid hormones and their receptors needs to be specific to avoid affecting other body systems.

However, they are difficult to target individually due to their high numbers and so there are currently no anti-obesity drugs that target them.

Now, researchers from Imperial and colleagues have found a potential way to target specific TRs located only in the hypothalamus, an area of the brain that regulates appetite. The authors say the findings might lead to developing a new type anti-obesity drug in the future.

Dr James Gardiner, lead author of the research from Imperial's Department of Medicine, said: "Our hope is that these findings could ultimately lead towards drugs that target thyroid hormones as a way to reduce someone's appetite and help them control their weight. We haven't been able to target these hormones before without lots of side effects, but in this study we've been able to be very specific about which hormones we're targeting, which should greatly lessen potential side effects. We are excited to see where this might lead in the future fight against obesity."

In this research, the authors divided 21 mice, who weighed roughly 20g each, into two groups. They injected mice in the first group with viruses that inactivated the brain TRs, but did not inject the second group. They then let both groups eat as much as they chose. Afterwards, the researchers examined the brains of the mice to confirm the virus had in fact inactivated the targeted receptors.

They found that the group of mice with the inactive TRs ate much more food and doubled in weight on average, doubling in size from the baseline of 20 grams to 40 grams over six weeks. The mice with active TRs maintained a stable body weight at 20 grams.

The authors say this is evidence that when targeting drugs to a specific, local, receptor in the correct area, they can alter appetite in these mice without causing other side effects. This could potentially be applied to humans in the future, where a drug might decrease a person's by activating TRs in the hypothalamus, without causing effects in other parts of the body. Dr Gardiner said: "If our findings can be applied to humans, then we may have a new target for obesity medication."

Humans with lowered thyroid receptor activity in their brains have previously been found to be on average more obese than others. If this research continues into testing drugs on human subjects, there would be no simple test to measure levels of receptor activity and adjust medication accordingly. Rather, treatment would be based on a system of trial and error with regard to whether the drug worked for specific individuals.

However, the authors warned that this research is at an early stage and the results should be taken with caution. Dr Gardiner added: "Due to the justifiably long and complex process of drug discovery, any potential treatment that could result from this will be far off in the future. However, the strength of our results, and the doubling in body size of these , shows there's that the role of and their are definitely worth exploring further in the fight against obesity."

Explore further: Potential obesity treatment targets the two sides of appetite: Hunger and feeling full

Related Stories

Potential obesity treatment targets the two sides of appetite: Hunger and feeling full

May 13, 2015
Our bodies' hormones work together to tell us when to eat and when to stop. But for many people who are obese, this system is off-balance. Now scientists have designed a hormone-like compound to suppress hunger and boost ...

Bone-derived hormone suppresses appetite in mice

March 8, 2017
A hormone secreted by bone cells can suppress appetite, according to mouse studies conducted by Columbia University Medical Center (CUMC) researchers. The hormone—called lipocalin 2—turns on neurons in the brain that ...

Scientists show protective effects of suppressing thyroid hormone receptors in retina

May 11, 2017
New research published online in The FASEB Journal suggests that the suppression of thyroid hormone receptor activity locally in the retina protects cone photoreceptor cells in mouse models of human retinal degenerative diseases. ...

Neuronal stimulation regulates appetite and glucose levels in mice

February 21, 2017
Drugs that target signaling by glucagon-like peptide (GLP-1) in the gut and pancreas are commonly used to regulate hypoglycemia in patients with type II diabetes. However, these drugs are associated with a number of unpleasant ...

Rap1, a potential new target to treat obesity

October 21, 2016
Scientists at Baylor College of Medicine, the National Institutes of Health and Virginia Tech Carilion Research Institute have discovered a new mechanism in the mouse brain that regulates obesity. The study, which appears ...

Rap1, a potential new target to treat obesity

September 13, 2016
Scientists at Baylor College of Medicine, the National Institutes of Health and Virginia Tech Carilion Research Institute have discovered a new mechanism in the mouse brain that regulates obesity. The study, which appears ...

Recommended for you

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

Large variety of microbial communities found to live along female reproductive tract

October 18, 2017
(Medical Xpress)—A large team of researchers from China (and one each from Norway and Denmark) has found that the female reproductive tract is host to a far richer microbial community than has been thought. In their paper ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.